<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neural Transm (Vienna)</journal-id>
<journal-id journal-id-type="iso-abbrev">J Neural Transm (Vienna)</journal-id>
<journal-title-group>
<journal-title>Journal of Neural Transmission</journal-title>
</journal-title-group>
<issn pub-type="ppub">0300-9564</issn>
<issn pub-type="epub">1435-1463</issn>
<publisher>
<publisher-name>Springer Vienna</publisher-name>
<publisher-loc>Vienna</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30923918</article-id>
<article-id pub-id-type="pmc">6456487</article-id>
<article-id pub-id-type="publisher-id">1998</article-id>
<article-id pub-id-type="doi">10.1007/s00702-019-01998-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry and Preclinical Psychiatric Studies - Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8505-7265</contrib-id>
<name>
<surname>Grünblatt</surname>
<given-names>Edna</given-names>
</name>
<address>
<phone>+41 43 556 4039</phone>
<email>edna.gruenblatt@kjpd.uzh.ch</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Werling</surname>
<given-names>Anna Maria</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roth</surname>
<given-names>Alexander</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Romanos</surname>
<given-names>Marcel</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walitza</surname>
<given-names>Susanne</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Department of Child and Adolescent Psychiatry and Psychotherapy, </institution><institution>University Hospital of Psychiatry Zurich, University of Zurich, </institution></institution-wrap>Zurich, Switzerland </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Neuroscience Center Zurich, </institution><institution>University of Zurich and ETH Zurich, </institution></institution-wrap>Zurich, Switzerland </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Zurich Center for Integrative Human Physiology, </institution><institution>University of Zurich, </institution></institution-wrap>Zurich, Switzerland </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1378 7891</institution-id><institution-id institution-id-type="GRID">grid.411760.5</institution-id><institution>Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, </institution><institution>University Hospital of Wuerzburg, </institution></institution-wrap>Würzburg, Germany </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0478 9977</institution-id><institution-id institution-id-type="GRID">grid.412004.3</institution-id><institution>Translational Molecular Psychiatry, Department of Child and Adolescent Psychiatry and Psychotherapy, Centre for Child and Adolescent Psychiatry Research, </institution><institution>University Hospital of Psychiatry Zurich, </institution></institution-wrap>Wagistrasse 12, 8952 Schlieren, Switzerland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>28</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>126</volume>
<issue>4</issue>
<fpage>517</fpage>
<lpage>529</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Attention-deficit hyperactivity disorder (ADHD) has been postulated to associate with dopaminergic dysfunction, including the dopamine transporter (DAT1). Several meta-analyses showed small but significant association between the 10-repeat allele in the <italic>DAT1</italic> gene in 3′-untranslated region variant number tandem repeat polymorphism and child and adolescent ADHD, whereas in adult ADHD the 9-repeat allele was suggested to confer as risk allele. Interestingly, recent evidence indicated that the long-allele variants (10 repeats and longer) might confer to lower expression of the transporter in comparison to the short-allele. Therefore, we assessed here the association in samples consisting of families with child and adolescent ADHD as well as a case–control sample, using either the 10- versus 9-repeat or the long- versus short-allele approach. Following, we conducted a systematic review and meta-analysis, including family and case–control studies, using the two aforementioned approaches as well as stratifying to age and ethnicity. The first approach (10-repeat) resulted in nominal significant association in child and adolescent ADHD (OR 1.1050 <italic>p</italic> = 0.0128), that became significant stratifying to European population (OR 1.1301 <italic>p</italic> = 0.0085). The second approach (long-allele) resulted in significant association with the whole ADHD population (OR 1.1046 <italic>p</italic> = 0.0048), followed by significant association for child and adolescent ADHD (OR 1.1602 <italic>p</italic> = 0.0006) and in Caucasian and in European child and adolescent ADHD (OR 1.1310 <italic>p</italic> = 0.0114; OR 1.1661 <italic>p</italic> = 0.0061; respectively). We were not able to confirm the association reported in adults using both approaches. In conclusion, we found further indication for a possible <italic>DAT1</italic> gene involvement; however, further studies should be conducted with stringent phenotyping to reduce heterogeneity, a limitation observed in most included studies.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1007/s00702-019-01998-x) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Attention-deficit hyperactivity disorder</kwd>
<kwd>ADHD</kwd>
<kwd>Dopamine transporter</kwd>
<kwd>DAT1</kwd>
<kwd>
<italic>SLC6A3</italic>
</kwd>
<kwd>Meta-analysis</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006447</institution-id>
<institution>Universität Zürich</institution>
</institution-wrap>
</funding-source>
<award-id>Filling the Gap</award-id>
<principal-award-recipient>
<name>
<surname>Werling</surname>
<given-names>Anna Maria</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id>
<institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution>
</institution-wrap>
</funding-source>
<award-id>320030-130237</award-id>
<principal-award-recipient>
<name>
<surname>Walitza</surname>
<given-names>Susanne</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer-Verlag GmbH Austria, part of Springer Nature 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Attention-deficit hyperactivity disorder (ADHD), characterized by persistent symptoms of inattention, hyperactivity and impulsivity, is one of the most common psychiatric and behavioural disorders in children and adolescents, with more than 5% of the paediatric population affected worldwide, and ADHD often persists into adulthood with a prevalence of 2.5–4.9% in adults (Thomas et al. <xref ref-type="bibr" rid="CR107">2015</xref>; Polanczyk et al. <xref ref-type="bibr" rid="CR91">2014</xref>). ADHD has been shown to have a high genetic component with around 80% heritability (Faraone and Larsson <xref ref-type="bibr" rid="CR30">2018</xref>). A recent genome-wide association study of over 20,000 ADHD patients has identified 12 independent loci to be genome-wide significantly associated with ADHD (Demontis et al. <xref ref-type="bibr" rid="CR21">2019</xref>). Nevertheless, genetic variations such as variable number tandem repeats (VNTRs) cannot be captured on such arrays, and therefore, conventional gene association studies may provide further information. One of these VNTRs (rs28363170), located on the dopamine transporter gene (<italic>SLC6A3</italic> / <italic>DAT1</italic>) in the 3′ untranslated region (UTR), with the 10- and 9-repeat alleles that are most common (Doucette-Stamm et al. <xref ref-type="bibr" rid="CR23">1995</xref>), were found to be associated with ADHD. In particular, the 10-repeat allele was described in several meta-analyses to associate with child and adolescent ADHD, though with a rather low effect size and in most cases with high heterogeneity between studies due to clinical phenotyping, age and ethnicity (Gizer et al. <xref ref-type="bibr" rid="CR43">2009</xref>; Yang et al. <xref ref-type="bibr" rid="CR119">2007</xref>). Nevertheless, further studies kept looking into the association between <italic>DAT1</italic> gene and ADHD, also due to significant linkage findings with the chromosomal location 5p13 containing the gene and ADHD (Friedel et al. <xref ref-type="bibr" rid="CR37">2007</xref>). Since it is known that there are further variants (3–13-repeats) on the <italic>DAT1</italic> 3′-UTR VNTR, expressing in various ethnicities in different frequencies (Mazei-Robinson and Blakely <xref ref-type="bibr" rid="CR79">2006</xref>), some studies looked also into associations with the 9- or the 11-repeat alleles. However, no association has been detected in child and adolescent ADHD both in European and Asian ethnicity (Li et al. <xref ref-type="bibr" rid="CR68">2006</xref>), whereas in adult ADHD a trend for association was found for 9-repeat allele carriers following a recent meta-analysis (Bonvicini et al. <xref ref-type="bibr" rid="CR10">2016</xref>).</p>
<p id="Par3">The dopamine transporter is a key player in the dopaminergic system, regulating the synaptic dopamine homeostasis and its signalling. Since psychostimulants, such as amphetamine and methylphenidate, provide an effective treatment for ADHD (e.g., Faraone and Buitelaar <xref ref-type="bibr" rid="CR29">2010</xref>), are known to have high affinity to the transporter and inhibiting the transporter (Markowitz and Patrick <xref ref-type="bibr" rid="CR76">2008</xref>; Han and Gu <xref ref-type="bibr" rid="CR47">2006</xref>), the dopamine transporter has become one of the risk candidates for ADHD research. Dopamine controls numerous functions including attention, mood, cognition, reward and movement (Iversen and Iversen <xref ref-type="bibr" rid="CR56">2007</xref>). And altered dopamine homeostasis and particularly dopamine transporter is not exclusive for ADHD, but has been implicated in several disorders, including paediatric Bipolar Disorder (rs40184) (Mick et al. <xref ref-type="bibr" rid="CR82">2008</xref>), Major Depressive Disorder (9-repeat) (Lopez-Leon et al. <xref ref-type="bibr" rid="CR73">2008</xref>), Posttraumatic Stress Disorder (9-repeat) (Li et al. <xref ref-type="bibr" rid="CR69">2016</xref>), Tourette Syndrome (9-repeat associated with increased tics) (Tarnok et al. <xref ref-type="bibr" rid="CR103">2007</xref>), Obsessive–Compulsive Disorder (9-repeat) (Taylor <xref ref-type="bibr" rid="CR104">2013</xref>), Alzheimer’s disease (9-repeat) (Feher et al. <xref ref-type="bibr" rid="CR32">2014</xref>) and Alcoholism (9-repeat associated with alcohol withdrawal seizure and delirium tremens) (Du et al. <xref ref-type="bibr" rid="CR25">2011</xref>), while no association was found in Schizophrenia (Gamma et al. <xref ref-type="bibr" rid="CR40">2005</xref>)(see also meta-analysis in <ext-link ext-link-type="uri" xlink:href="http://www.szgene.org">http://www.szgene.org</ext-link>) and Parkinson’s disease (Geissler et al. <xref ref-type="bibr" rid="CR41">2017</xref>) [for detailed review on dopamine transporter and various CNS disorders see (McHugh and Buckley <xref ref-type="bibr" rid="CR80">2015</xref>)]. However most studies demonstrated either conflicting findings or having only a single finding lacking replications or having no significant findings. In a meta-analysis of a collection of naturalistic studies ADHD children without 10/10-repeat genotypes responded better to methylphenidate; however, this effect was not found in clinically monitored studies (Soleimani et al. <xref ref-type="bibr" rid="CR100">2018</xref>). On the other hand, Parkinson’s disease carriers of the 9-repeat allele required lower levopoda doses, as well as were at risk of hallucination/psychosis following treatment (Politi et al. <xref ref-type="bibr" rid="CR92">2018</xref>). Similarly, in methamphetamine substance use, 9-repeat was shown to be a strong risk factor for a worse prognosis of methamphetamine psychosis (Ujike et al. <xref ref-type="bibr" rid="CR109">2003</xref>).</p>
<p id="Par4">Investigation regarding the functional consequence of the aforementioned variants has shown some mixed results. In vitro, using various cell culture models and reporter gene designs, showed either the 9- or the 10-repeat to increase <italic>DAT1</italic> gene expression (Fuke et al. <xref ref-type="bibr" rid="CR38">2001</xref>; VanNess et al. <xref ref-type="bibr" rid="CR110">2005</xref>; Mill et al. <xref ref-type="bibr" rid="CR84">2005</xref>; Greenwood and Kelsoe <xref ref-type="bibr" rid="CR45">2003</xref>; Inoue-Murayama et al. <xref ref-type="bibr" rid="CR55">2002</xref>; Hill et al. <xref ref-type="bibr" rid="CR52">2010</xref>; Miller and Madras <xref ref-type="bibr" rid="CR85">2002</xref>). Ex vivo, gene expression in post-mortem brain as well as in periphery also showed some inconsistent results [3 monkey substantia nigra (SN) (Miller and Madras <xref ref-type="bibr" rid="CR85">2002</xref>], 20 post-mortem cerebellum and temporal lobe and 18 volunteers lymphocytes (Mill et al. <xref ref-type="bibr" rid="CR83">2002</xref>), 7 post-mortem midbrain (Brookes et al. <xref ref-type="bibr" rid="CR13">2007</xref>), post-mortem of 30 Alzheimer’s disease SN and polar region of the frontal lobe (Pinsonneault et al. <xref ref-type="bibr" rid="CR90">2011</xref>), post-mortem of the ventral midbrain from 18 controls and 18 cocaine users (Zhou et al. <xref ref-type="bibr" rid="CR120">2014</xref>). To our knowledge, no data are available linking between central nervous system and blood <italic>DAT1</italic> expression and <italic>DAT1</italic> genotypes. However, Wiers et al. (<xref ref-type="bibr" rid="CR115">2018</xref>) reported correlations in a small post-mortem study investigating <italic>DAT1</italic> mRNA expression in SN of 3 adult ADHD and 13 controls and DAT protein expression in the Caudate. Indeed, they found a significant positive correlation between mRNA and protein expression in the two brain regions (Wiers et al. <xref ref-type="bibr" rid="CR115">2018</xref>). Furthermore, DNA methylation of the <italic>DAT1</italic> cluster A in blood was significantly correlated with the DNA methylation of the <italic>DAT1</italic> cluster A in SN (Wiers et al. <xref ref-type="bibr" rid="CR115">2018</xref>). In a recent meta-analysis of a collection of positron emission tomography (PET) a highly significant evidence for the 9-repeat allele was shown to be associated with increased dopamine-transporter activity in human adults, that was significant in healthy adults and only marginally significant in adult ADHD patients (Faraone et al. <xref ref-type="bibr" rid="CR31">2014</xref>). In the single-photon emission computed tomography (SPECT) analysis, although containing small sample size, similar results were obtained for healthy adults, while for affected adults (ADHD, Parkinson’s disease, Schizophrenia, and alcoholism) the opposite results were observed (Faraone et al. <xref ref-type="bibr" rid="CR31">2014</xref>). Interestingly, in adult age span (20–75 years of age) 10-repeat homozygotes showed reduced striatal activity during working memory task that reduced with age, that led to the hypothesis of earlier manifestation of cognitive impairment in 10-repeat homozygotes (Sambataro et al. <xref ref-type="bibr" rid="CR95">2015</xref>). Yet, most studies focused on the functional effects of the most frequent repeats, the 9- and 10-repeats, while few studies looked whether the other variants have any functional effect. In a recent study, the binding of HESR1 and two transcription factors, known to bind at the VNTR-site of the <italic>DAT1</italic> gene, was found to be inhibited depending on the length of the VNTR variant, with 11-repeats having low <italic>DAT1</italic> expression compared to the short variants up to 6-repeats (Kanno and Ishiura <xref ref-type="bibr" rid="CR60">2011</xref>). Moreover, the non-coding RNA, miR-491 was found to inhibit <italic>DAT1</italic> expression in a dose-dependent manner, in which higher repeat number (11-repeats) inhibited the expression compared to low number of repeats (up to 1-repeat) (Jia et al. <xref ref-type="bibr" rid="CR57">2016</xref>).</p>
<p id="Par5">Therefore, in the current case–control and family study, we assessed whether the association between <italic>DAT</italic> 3′-UTR VNTR 10-repeat carriers or long-allele (10-repeats and higher) carriers conveys a risk for ADHD. In addition, we conducted a systematic review of the literature followed by an updated meta-analysis, including all current available associations with <italic>DAT1</italic> 3′-UTR VNTR for case–control and family studies in child and adolescent as well as adult ADHD in various ethnicities. To address the possible confounding effects by age of patients, and their ethnicity, a stratified meta-analysis for each variable was conducted.</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Study samples</title>
<p id="Par6">Two hundred and two Caucasian nuclear families (146 families with both parents and 56 families with 1 parent) were recruited and the index patients were investigated in the in- and outpatient units and the day clinics of the Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich. Families were included if at least the index patient fulfilled the diagnostic criteria for ADHD (F90.0 or F90.1) according to ICD-10 (World Health Organization <xref ref-type="bibr" rid="CR118">2016</xref>; Dilling et al. <xref ref-type="bibr" rid="CR22">1996</xref>). Accordingly, this resulted in total 738 individuals [202 index with ADHD (males = 153, females = 49); aged 12.62 ± 3.05; IQ 102.7 ± 13.2; 119 parents and sibs with ADHD (males = 41, females = 78) and 417 control parents and sibs (males = 194, females = 223)]. The ADHD diagnoses of the parents and siblings were reported by the parents. The clinical diagnostic assessment of the index patient was done by a child and adolescent psychiatrist or psychologist under supervision of a senior psychiatrist in the clinic. The index patient was required to be ≥ 6 years old and to have an IQ over 75 as assessed with either the Wechsler Intelligence Scale for Children (WISC) (Wechsler <xref ref-type="bibr" rid="CR113">1991</xref>; Tewes et al. <xref ref-type="bibr" rid="CR106">1999</xref>), the Kaufman Assessment Battery for Children (K-ABC) (Kaufman and Kaufman <xref ref-type="bibr" rid="CR61">1983</xref>; Melchers and Preuss <xref ref-type="bibr" rid="CR81">1994</xref>), the Culture Fair Test (CFT-20-R) (Weiss <xref ref-type="bibr" rid="CR114">2006</xref>), Snijders-Oomen Nonverbal Intelligence Test (SON-R) (Tellegen et al. <xref ref-type="bibr" rid="CR105">2003</xref>) or Intelligence and Development Scales (IDS) (Grob et al. <xref ref-type="bibr" rid="CR46">2009</xref>). Exclusion criteria were (a) no Caucasian origin, (b) potentially confounding and severe psychiatric diagnoses such as psychosis, any pervasive developmental disorder, primary mood or anxiety disorder and Tourette’s syndrome, (c) neurological disorders such as epilepsy, (d) a history of any acquired brain damage or evidence of the fetal alcohol syndrome, (e) premature deliveries (delivery before 37th gestational week) and/or (f) maternal reports of severe prenatal, perinatal or postnatal complications.</p>
<p id="Par7">In the case–control setting, the 220 index patients (males = 164, females = 56; aged 12.7 ± 2.98; IQ 103.2 ± 13.6) were compared to genetically independent 158 Caucasian healthy controls (males = 89, females = 69, aged 11.52 ± 3.091; IQ 111.5 ± 13.3) who were recruited at the Departments of Child and Adolescent Psychiatry of the Universities of Wuerzburg and Zurich. The cases in the case–control study consist of some index from the family study with additional new cases without family members recruited. Informed written consent was obtained in all cases from the participants and their parents. The study was approved by the ethical commissions of both of the involved universities in accordance with the latest version of the Declaration of Helsinki, including an ethical permission granted by the Ethic Committees from Wuerzburg, and the Cantonal Ethic Committee of Zurich (Ref. Nr. KFO 140/03 and KEK-ZH-Nr. 2016-00101).</p>
</sec>
<sec id="Sec4">
<title>Genotyping</title>
<p id="Par8">DNA was isolated either from whole blood collected in ethylenediaminetetraacetic acid (EDTA) tubes using QIAamp DNA Blood Maxi Kit (Qiagen), or from saliva collected in the Oragene DNA collection kit (DNA Genotek, Canada) and isolated as per manufacturer’s protocol. DNA concentrations, A260/A280, and A260/A230 ratios were measured using a spectrophotometer (NanoVue Plus, GE). The study population was genotyped for the DAT1 3′-UTR VNTR polymorphism, using the primers F: 5′-TGTGGTGTAGGGAACGGCCTGAG-3′ and R: 5′-CTTCCTGGAGGTCACGGCTCAAGG-3′. A total volume of 25 µl containing 1 µl DNA sample (50 ng/µl) were mixed with 12.5 µl Promega GoTaq<sup>®</sup> Green Master Mix (Promega), 9.5 µl water and 1 µl of both primers (forward and reverse 10 µM). The reaction was performed in 0.2 ml PCR 8-tube strips, sealed with individually attached caps (Bio-Rad) in a C1000™ CFX96™ Thermal cycler (Bio-Rad). DNA amplification was achieved under the following conditions: 2 min at 95 °C followed by 30 cycles at 95 °C for 45 s, 67.5 °C for 45 s, 72 °C for 1 min, and a final extension of 5 min at 72 °C. 15 µl of PCR product was loaded into a 3% agarose gel (SeaKem<sup>®</sup> LE Agarose mixed with 1x TAE buffer) stained with 5 µl HDGreen™ Plus DNA Stain (Intas) per 100 g agarose and run for 90 min at 120 V. A 100 bp BenchTop DNA ladder (Promega) was used to assess the size of the PCR product and set the genotypes according to the expected bands of 316 bp for 6-repeat allele, 396 bp for 8-repeat allele, 436 bp for 9-repeat allele, 476 bp for 10-repeat allele and 516 bp for 11-repeat allele. PCR were run for sample DNA samples in duplicates to ensure reproducibility. In case of ambiguity in the duplicates, genotyping was repeated in a separate run to resolve the discrepancy. No-template controls (NTC) were included in every run to exclude impurities.</p>
</sec>
<sec id="Sec5">
<title>Statistical analysis</title>
<p id="Par9">All association studies were run on the PLINK v1.7 [URL: <ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/purcell/plink/">http://pngu.mgh.harvard.edu/purcell/plink/</ext-link> (Purcell et al. <xref ref-type="bibr" rid="CR93">2007</xref>)]. Each study group (case–control study) was tested for Hardy–Weinberg equilibrium (HWE) that confirmed no deviations from HWE for all samples. For the case–control association study Fisher’s Exact Test was conducted and significance was set at <italic>p</italic> &lt; 0.025 as Bonferroni correction was conducted (analysis of the <italic>DAT1</italic> in two forms: long-allele vs. short-allele and 10-repeat vs. 9-repeat). For the family association study, Mendel errors test (none were found) followed by the transmission disequilibrium test (TDT) was conducted as well as a parent-of-origin analysis.</p>
</sec>
<sec id="Sec6">
<title>Search strategy and study selection</title>
<p id="Par10">A systematic literature search was conducted to include studies that examined associations of <italic>DAT1</italic> 3′-UTR VNTR polymorphisms with ADHD. We searched PubMed and Web of Science databases for articles published until December 31, 2018. Literature was searched using the keywords: (DAT* OR SLC6A3 OR “dopamine transporter”) AND (polymorphism* OR VNTR OR “tandem repeat” OR “untranslated region”) AND (ADHD OR “attention hyperactivity”). As a further search manner, we searched the reference sections of the most recently published studies identified in literature search described above, as well as any recently published systematic review articles and meta-analysis, to identify studies that might have been missed. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram (Liberati et al. <xref ref-type="bibr" rid="CR70">2009</xref>) was used to report the search flow for this meta-analysis. Studies included in our meta-analysis had to fulfil the following criteria: (1) detailed description of the sample size, ancestry of participants, and diagnostic criteria for ADHD, (2) case–control or family studies examining the association between <italic>DAT1</italic> 3′-UTR VNTR polymorphism and ADHD, and (3) containing data on allele/genotype frequencies in case and control groups and/or odds ratio (OR) and 95% confidence interval (CI) for the OR, (4) samples not duplicative of other studies. In addition to performing a meta-analysis of all studies pooled together, we conducted a subgroup analysis by dividing the studies into those including patients with Caucasian or Asian ancestry to examine the effects of ethnic heterogeneity as well as for adult versus child and adolescent ADHD. If articles only reported allele/genotype frequencies, OR and 95% CI was calculated from allele frequencies using an online OR calculator (<ext-link ext-link-type="uri" xlink:href="https://www.genecalculators.net/associatorrr-cc.html">https://www.genecalculators.net/associatorrr-cc.html</ext-link>). Corresponding authors and co-authors were contacted in case of missing data in the selected publications, and were asked to provide the missing information. In case of no respond, articles were excluded (<italic>n</italic> = 4).</p>
</sec>
<sec id="Sec7">
<title>Data synthesis and statistical analysis</title>
<p id="Par11">The quality of all included studies was assessed based on traditional epidemiological considerations for genetic studies as previously described in Liu et al. (<xref ref-type="bibr" rid="CR72">2015</xref>; Supplementary Table S1). The meta-analysis was conducted using the MIX 2.0-Professional software for meta-analysis in Excel, version 2.0.1.6 (<ext-link ext-link-type="uri" xlink:href="http://www.meta-analysis-made-easy.com/">http://www.meta-analysis-made-easy.com/</ext-link>) (Bax et al. <xref ref-type="bibr" rid="CR6">2006</xref>). The OR of each study was converted to the natural logarithm of OR [Ln (OR)], and 95% CI to standard error (SE) using MIX 2.0 software. The Ln (OR), SE, and sample size (<italic>N</italic>) were used in the software to perform heterogeneity statistics, heterogeneity funnel plots, and synthesis forest plots using inverse variance weighting. The heterogeneity between studies was assessed by Cochran’s Chi square-based <italic>Q</italic> statistic and the inconsistency index (<italic>I</italic><sup>2</sup>), with <italic>p</italic> &lt; 0.05 being considered statistically significant. If there was significant (<italic>p</italic> &lt; 0.05) heterogeneity between studies, we used the random-effects model, otherwise we used the fixed-effects model. The random-effects model considers both between-study and within-study variation, whereas the fixed-effects model considers only within-study variation (Borenstein et al. <xref ref-type="bibr" rid="CR11">2010</xref>). The heterogeneity <italic>I</italic><sup>2</sup> are presented in Supplementary Tables S2 and S3. Potential publication bias was assessed using Begg’s test (Begg and Mazumdar <xref ref-type="bibr" rid="CR7">1994</xref>) and Egger’s regression test (Egger et al. <xref ref-type="bibr" rid="CR27">1997</xref>), with <italic>p</italic> &lt; 0.05 considered statistically significant (Supplementary Tables S2 and S3). In case of <italic>p</italic> &lt; 0.05 for publication bias, the trim and fill correction was conducted to explore the corrected OR and 95% CI (Duval and Tweedie <xref ref-type="bibr" rid="CR26">2000</xref>).</p>
</sec>
</sec>
<sec id="Sec8" sec-type="results">
<title>Results</title>
<sec id="Sec9">
<title>DAT1 3′-UTR VNTR association with child and adolescent ADHD in the Zurich samples</title>
<p id="Par12">In the case–control study a nominal significant association between <italic>DAT1</italic> 3′-UTR VNTR long-allele and ADHD was observed (OR 0.697, 95% CI 0.501–0.972, <italic>p</italic> = 0.03). Furthermore, a significant association was found when assessing according to 10-repeat allele versus 9-repeat allele carriers (OR 0.676, 95% CI 0.484–0.945, <italic>p</italic> = 0.024). Test statistic was based on 211 cases and 155 controls, and genotypes are presented in Table <xref ref-type="table" rid="Tab1">1</xref>a.</p>
<p id="Par13">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Genotype distribution of the <italic>DAT1</italic> 3′-UTR VNTR in both Zurich samples</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="7">(a) Case–control study sample</th></tr><tr><th align="left" rowspan="2"></th><th align="left" colspan="6"><italic>DAT1</italic> 3′-UTR VNTR genotypes</th></tr><tr><th align="left">9/9</th><th align="left">10/9</th><th align="left">11/9</th><th align="left">10/10</th><th align="left">10/11</th><th align="left">11/11</th></tr></thead><tbody><tr><td align="left">ADHD</td><td align="char" char=".">22</td><td align="char" char=".">88</td><td align="char" char=".">2</td><td align="char" char=".">101</td><td align="char" char=".">6</td><td align="char" char=".">1</td></tr><tr><td align="left">Control</td><td align="char" char=".">9</td><td align="char" char=".">54</td><td align="char" char=".">1</td><td align="char" char=".">90</td><td align="char" char=".">2</td><td align="char" char=".">0</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="7">(b) Family study sample</th></tr><tr><th align="left" rowspan="2"></th><th align="left" colspan="6"><italic>DAT1</italic> 3′-UTR VNTR genotypes</th></tr><tr><th align="left">9/9</th><th align="left">10/9</th><th align="left">11/9</th><th align="left">10/10</th><th align="left">10/11</th><th align="left">11/11</th></tr></thead><tbody><tr><td align="left">ADHD</td><td align="char" char=".">19</td><td align="char" char=".">82</td><td align="char" char=".">1</td><td align="char" char=".">94</td><td align="char" char=".">5</td><td align="char" char=".">1</td></tr><tr><td align="left">Mother</td><td align="char" char=".">28</td><td align="char" char=".">80</td><td align="char" char=".">2</td><td align="char" char=".">84</td><td align="char" char=".">2</td><td align="char" char=".">1</td></tr><tr><td align="left">Father</td><td align="char" char=".">8</td><td align="char" char=".">53</td><td align="char" char=".">1</td><td align="char" char=".">87</td><td align="char" char=".">2</td><td align="char" char=".">1</td></tr><tr><td align="left">Sibs</td><td align="char" char=".">13</td><td align="char" char=".">84</td><td align="char" char=".">0</td><td align="char" char=".">93</td><td align="char" char=".">2</td><td align="char" char=".">0</td></tr></tbody></table></table-wrap>
</p>
<p id="Par14">Family-based association analyses of the <italic>DAT1</italic> 3′-UTR VNTR long-allele as well as the 10-repeat versus 9-repeat allele yielded no significant association in the Zurich sample (OR 1.015, 95% CI 0.726–1.418, <italic>p</italic> = 0.932; OR 1.048, 95% CI 0.742–1.480, <italic>p</italic> = 0.792; respectively). Data from 46 heterozygous parents were included to assess the TDT, and genotypes are presented in Table <xref ref-type="table" rid="Tab1">1</xref>b.</p>
</sec>
<sec id="Sec10">
<title>Meta-analysis for <italic>DAT1</italic> 3′-UTR VNTR association with child, adolescent, and adult ADHD in different ethnical groups</title>
<p id="Par15">The literature search for studies reporting on the association of <italic>DAT1</italic> 3′-UTR VNTR with ADHD identified 899 non-duplicated articles (Supplementary Figure S1). Out of 861 articles, 767 articles were excluded at the title/abstract level. Altogether, 100 articles were read fully, and 34 articles were excluded because various reasons: e.g., missing data, overlapping samples in other publications or not fulfilling the inclusion criteria (Supplementary Table S4). Finally, 61 publications were included in the meta-analysis (Supplementary Table S5 including studies characteristics, demographics and quality assessment scores), including the current study results (Cook et al. <xref ref-type="bibr" rid="CR17">1995</xref>; Waldman et al. <xref ref-type="bibr" rid="CR111">1998</xref>; Jiang et al. <xref ref-type="bibr" rid="CR58">1999</xref>; Lunetta et al. <xref ref-type="bibr" rid="CR74">2000</xref>; Swanson et al. <xref ref-type="bibr" rid="CR102">2000</xref>; Curran et al. <xref ref-type="bibr" rid="CR18">2001</xref>; Todd et al. <xref ref-type="bibr" rid="CR108">2001</xref>; Maher et al. <xref ref-type="bibr" rid="CR75">2002</xref>; Smith et al. <xref ref-type="bibr" rid="CR99">2003</xref>; Carrasco et al. <xref ref-type="bibr" rid="CR15">2004</xref>; Kustanovich et al. <xref ref-type="bibr" rid="CR66">2004</xref>; Galili-Weisstub et al. <xref ref-type="bibr" rid="CR39">2005</xref>; Bakker et al. <xref ref-type="bibr" rid="CR4">2005</xref>; Bobb et al. <xref ref-type="bibr" rid="CR9">2005</xref>; Feng et al. <xref ref-type="bibr" rid="CR33">2005</xref>; Kim et al. <xref ref-type="bibr" rid="CR63">2005</xref>, <xref ref-type="bibr" rid="CR64">2006</xref>; Langley et al. <xref ref-type="bibr" rid="CR67">2005</xref>; Simsek et al. <xref ref-type="bibr" rid="CR98">2005</xref>; Hawi et al. <xref ref-type="bibr" rid="CR49">2005</xref>, <xref ref-type="bibr" rid="CR50">2010</xref>; Brookes et al. <xref ref-type="bibr" rid="CR12">2006</xref>; Cheuk et al. <xref ref-type="bibr" rid="CR16">2006</xref>; Hebebrand et al. <xref ref-type="bibr" rid="CR51">2006</xref>; Lim et al. <xref ref-type="bibr" rid="CR71">2006</xref>; Asherson et al. <xref ref-type="bibr" rid="CR3">2007</xref>; Brüggemann et al. <xref ref-type="bibr" rid="CR14">2007</xref>; Qian et al. <xref ref-type="bibr" rid="CR94">2007</xref>; Genro et al. <xref ref-type="bibr" rid="CR42">2008</xref>; Johansson et al. <xref ref-type="bibr" rid="CR59">2008</xref>; Wang et al. <xref ref-type="bibr" rid="CR112">2008</xref>; Banoei et al. <xref ref-type="bibr" rid="CR5">2008</xref>; Kopeckova et al. <xref ref-type="bibr" rid="CR65">2008</xref>; Franke et al. <xref ref-type="bibr" rid="CR35">2008</xref>, <xref ref-type="bibr" rid="CR36">2010</xref>; Niederhofer et al. <xref ref-type="bibr" rid="CR87">2008</xref>; Kereszturi et al. <xref ref-type="bibr" rid="CR62">2008</xref>; Gizer et al. <xref ref-type="bibr" rid="CR43">2009</xref>; Wohl et al. <xref ref-type="bibr" rid="CR117">2008</xref>; Martinez-Levy et al. <xref ref-type="bibr" rid="CR77">2009</xref>, <xref ref-type="bibr" rid="CR78">2013</xref>; Dresler et al. <xref ref-type="bibr" rid="CR24">2010</xref>; Aparecida da Silva et al. <xref ref-type="bibr" rid="CR2">2011</xref>; Bidwell et al. <xref ref-type="bibr" rid="CR8">2011</xref>; Das et al. <xref ref-type="bibr" rid="CR19">2011</xref>; El-Tarras et al. <xref ref-type="bibr" rid="CR28">2012</xref>; Hoogman et al. <xref ref-type="bibr" rid="CR54">2013</xref>; de Azeredo et al. <xref ref-type="bibr" rid="CR20">2014</xref>; Shang and Gau <xref ref-type="bibr" rid="CR97">2014</xref>; Hasler et al. <xref ref-type="bibr" rid="CR48">2015</xref>; Sery et al. <xref ref-type="bibr" rid="CR96">2015</xref>; Fonseca et al. <xref ref-type="bibr" rid="CR34">2015</xref>; Agudelo et al. <xref ref-type="bibr" rid="CR1">2015</xref>; Gomez-Sanchez et al. <xref ref-type="bibr" rid="CR44">2016</xref>; Onnink et al. <xref ref-type="bibr" rid="CR88">2016</xref>; Ortega-Rojas et al. <xref ref-type="bibr" rid="CR89">2017</xref>; Stanley et al. <xref ref-type="bibr" rid="CR101">2017</xref>; Wiguna et al. <xref ref-type="bibr" rid="CR116">2017</xref>; Hong et al. <xref ref-type="bibr" rid="CR53">2018</xref>; Morgan et al. <xref ref-type="bibr" rid="CR86">2018</xref>). The summary of OR, SE, type of study (e.g., family TDT, case–control CC etc.), number of participants, age of cases (child and adolescent or adult ADHD), ethnicity/country, and the ID given for all studies included are presented in Supplementary Tables S6 and S7 (10-repeats vs. 9-repeats, and Long-allele vs. Short-allele, respectively). The meta-analyses summary of all <italic>DAT1</italic> 3′-UTR VNTR analysis variations (long-allele vs. short-allele; 10-repeat vs. 9-repeat) with the entire publications, stratified to age of cases (child and adolescent or adult ADHD) and ethnical grouping is presented in Supplementary Tables S2 and S3.</p>
<p id="Par16">We found no significant association between 10-repeat allele carriers and the entire ADHD population, as well as after stratifying to adult ADHD (Supplementary Tables S2). However, stratification to child and adolescent ADHD resulted in a nominal significant association (OR 1.1050 95% CI 1.0203–1.1968, <italic>p</italic> = 0.0128), nevertheless the analysis was accompanied with high heterogeneity that was not due to publications bias. Following ethnical stratification, children and adolescent ADHD originating from Europe demonstrated a significant association with 10-repeat allele as risk allele (OR 1.1301 95% CI 1.0316–1.2379, <italic>p</italic> = 0.0085), nevertheless, also here a significant heterogeneity was found. For further detailed stratifications results see Supplementary Table S2.</p>
<p id="Par17"><italic>DAT1</italic> 3′-UTR VNTR long-allele was significantly associated with ADHD assessed as the whole ADHD population (OR 1.1046 95% CI 1.0309–1.1837, <italic>p</italic> = 0.0048). Similarly to the 10-repeat analysis, significant heterogeneity was observed with publication bias. Following trim and fill correction the association was still significant with Long-allele as risk allele (OR 1.0614 95% CI 1.0186–1.1060). Following stratification with age, only child and adolescent ADHD kept the significant association (OR 1.1602 95% CI 1.0657–1.2631, <italic>p</italic> = 0.0006; Trim and Fill OR 1.1053 95% CI 1.0525–1.1605), however still with high heterogeneity. In Caucasian child and adolescent ADHD, and in European child and adolescent ADHD, a significant association with the Long-allele was found (OR 1.1310 95% CI 1.0282–1.2441, <italic>p</italic> = 0.0114; OR 1.1661 95% CI 1.0448–1.3015, <italic>p</italic> = 0.0061; respectively). In the whole Asian population a nominal significant association was observed, however following trim and fill correction significance was lost (OR 1.0991 95% CI 0.9240–1.3074). The forest and heterogeneity funnel plot for the whole ADHD sample is presented in Fig. <xref ref-type="fig" rid="Fig1">1</xref>a, b, and the forest plot results following stratification to age (child and adolescent-, adult-ADHD) is presented in Fig. <xref ref-type="fig" rid="Fig1">1</xref>c, d. Summary of the meta-analysis results for the ethnicity stratification is demonstrated in the world map in Fig. <xref ref-type="fig" rid="Fig2">2</xref>.</p>
<p id="Par18">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Meta-analysis of all cohorts and published association analyses (<italic>n</italic> = 71) of the <italic>DAT1</italic> 3′-UTR VNTR Long-allele with attention-deficit hyperactivity disorder (ADHD) (<bold>a</bold>). Heterogeneity funnel plot assessing any evidence of publication bias for whole ADHD studies <italic>I</italic><sup>2</sup> = 54.167% (95% CI 40.03–64.97%) <italic>p</italic> = 0 (<bold>b</bold>). Forest plot in child and adolescent ADHD studies (<italic>n</italic> = 59) (<bold>c</bold>). Forest plot in adult ADHD studies (<italic>n</italic> = 12) (<bold>d</bold>). Black whiskers in the forest plot represent 95% confidence intervals (CI) for odds ratio; the weight (inverse variance) of the study is reflected in symbol (box) size. Sample demographics, individual statistics, heterogeneity, literature bias statistics, quality assessments and scores, and model used is summarized in Supplementary Tables S3, S5–S6. The order of the samples is as presented in the Supplementary Tables and in Supplementary Figures S2–S4, in a descending manner</p></caption><graphic id="d29e1274" xlink:href="702_2019_1998_Fig1_HTML"></graphic></fig>
</p>
<p id="Par19">
<fig id="Fig2"><label>Fig. 2</label><caption><p>World map overview of the countries that were included in the child and adolescent ADHD meta-analysis (<italic>DAT1</italic> 3′-UTR VNTR Long-repeat allele as risk allele) according to the various stratifications. The odds ratio (OR) and 95% CI are displayed for each ethnicity category. <italic>p</italic> value &lt; 0.05*; &lt; 0.01**; &lt; 0.001***</p></caption><graphic id="d29e1292" xlink:href="702_2019_1998_Fig2_HTML"></graphic></fig>
</p>
</sec>
</sec>
<sec id="Sec11" sec-type="discussion">
<title>Discussion</title>
<p id="Par20">The current meta-analysis, could confirm previous findings showing weak association between the 10-repeat allele of the <italic>DAT1</italic> 3′-UTR VNTR gene and child and adolescent ADHD, that reached significance only in the European population; however, this was accompanied by high heterogeneity that was in some cases due to literature bias but in other cases due to heterogeneity in clinical phenotyping, age or ethnicity (Li et al. <xref ref-type="bibr" rid="CR68">2006</xref>; Gizer et al. <xref ref-type="bibr" rid="CR43">2009</xref>). On the other hand, we were not able to confirm a significant association between the 9-repeat allele and adult ADHD as previously reported (Bonvicini et al. <xref ref-type="bibr" rid="CR10">2016</xref>), and only a nominal significant association was observed for the European adult ADHD with 9-repeat as risk allele (see Supplementary Table S2).</p>
<p id="Par21">Interestingly, assessing the functional approach, in which the long-allele was suggested to result in decreased dopamine transporter expression (Faraone et al. <xref ref-type="bibr" rid="CR31">2014</xref>; Kanno and Ishiura <xref ref-type="bibr" rid="CR60">2011</xref>; Jia et al. <xref ref-type="bibr" rid="CR57">2016</xref>), seem to show significant association with ADHD. Indeed, the meta-analysis including the overall ADHD studies, as well as the child and adolescent ADHD, the Caucasian child and adolescent ADHD, the European child and adolescent ADHD, and nominally the Asian child and adolescent ADHD resulted in significant association with Long-allele as risk allele. In the other ethnical groups the associations did not reach significance, however all seem to show some tendency toward the long-allele as risk allele, however further studies should be conducted to confirm this hypothesis.</p>
<p id="Par22">The current study included the largest sample size available (total <italic>n</italic> = 40,681 consisting of 14,821 cases) for a powerful meta-analysis of the <italic>DAT1</italic> 3′-UTR VNTR gene variants, and used when needed the random-effects model that incorporate heterogeneity among trials (Borenstein et al. <xref ref-type="bibr" rid="CR11">2010</xref>). Indeed, following quality assessment of all included studies according to traditional epidemiological considerations (Liu et al. <xref ref-type="bibr" rid="CR72">2015</xref>) indicated that some studies did not reach high quality scores due to sample size, diagnostic criteria, recruitment strategies and quality control of the genetic analysis. This was reflected in significant heterogeneity, that in some cases, was also confirmed with significant publication bias assessed with Begg’s test (Begg and Mazumdar <xref ref-type="bibr" rid="CR7">1994</xref>) and Egger’s regression test (Egger et al. <xref ref-type="bibr" rid="CR27">1997</xref>). In these few cases we corrected the results using trim and fill correction (Duval and Tweedie <xref ref-type="bibr" rid="CR26">2000</xref>), that kept their significance even after correction.</p>
<p id="Par23">To summarize the current study, we could show further evidence of the <italic>DAT1</italic> 3′-UTR VNTR variants to play a role in ADHD, in particularly in child and adolescents with the Long-allele as risk allele. As previously hypothesized, this could indeed be due to the possible functional effect of the variants length in controlling the expression of the <italic>DAT1</italic> gene. However, as still high study heterogeneity was observed, with some studies not reaching high quality, further analysis is necessary to establish a robust conclusion.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec12">
<p>Below is the link to the electronic supplementary material.</p>
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="702_2019_1998_MOESM1_ESM.pdf"><caption><p>Supplementary material 1 (PDF 2756 KB)</p></caption></media></supplementary-material>
</p>
<p>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="702_2019_1998_MOESM2_ESM.pdf"><caption><p>Supplementary material 2 (PDF 438 KB)</p></caption></media></supplementary-material>
</p>
<p>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="702_2019_1998_MOESM3_ESM.pdf"><caption><p>Supplementary material 3 (PDF 439 KB)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>The authors thank the families, patients, and control volunteers who participated in this research. The authors would like to acknowledge Dr. Ian Gizer providing data from his meta-analysis from 2009, Dr. Susan Shur-Fen Gau, Dr. Chi-Yung Shang, Dr. Philip Asherson, Dr. Martine Hoogman, Dr. Marten Onnink, Dr. Mara Helena Hutz, Dr. Carlos S Cruz Fuentes, Dr. Gabriela Ariadna Martinez Levy, Dr. Kate Langley, Dr. Kanchan Mukhopadhyay, Mrs. Julia Morgan, Dr. Zsofia Nemoda, Dr. Jenny Ortega-Rojas, Dr. Ayusi Garcia Carmen and Dr. Clara Isabel Gomez Sanchez providing failing data of their publication and samples, Dr. Jie Li for translation of publications in Chinese into English, Ms. Rea Müller, Ms. Miryame Hofmann and Mrs. Susanne Kunert-Dümpelmann for their laboratory technical support. The authors acknowledge the Swiss National Science Foundation (Grant number SW 320030-130237) and the postdoctoral grant support for Anna Maria Werling by the University of Zurich, “Filling the Gap program”.</p>
</ack>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This project was supported by the Swiss National Science Foundation (Grant number SW 320030-130237) and the University of Zurich, “Filling the Gap program”.</p>
</notes>
<notes notes-type="COI-statement">
<title>Compliance with ethical standards</title>
<sec id="FPar1">
<title>Conflict of interest</title>
<p>S. Walitza has received in the last 5 years royalities from Thieme Hogrefe, Kohlhammer, Springer, Beltz. S. Walitza has received lecture honoraria from Opopharma in the last 5 years. Her work was supported in the last 5 years by the Swiss National Science Foundation (SNF), diff. EU FP7s, HSM Hochspezialisierte Medizin of the Kanton Zurich, Switzerland, Bfarm Germany, ZInEP, Hartmann Müller Stiftung, Olga Mayenfisch, Gertrud Thalmann Fonds. Outside professional activities and interests are declared under the link of the University of Zurich <ext-link ext-link-type="uri" xlink:href="http://www.uzh.ch/prof/ssl-dir/interessenbindungen/client/web/">http://www.uzh.ch/prof/ssl-dir/interessenbindungen/client/web/</ext-link>. The other authors declare no conflict of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agudelo</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Galvez</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Mateus</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Talero-Gutierrez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Velez-Van-Meerbeke</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder</article-title>
<source/>Neurologia
          <year>2015</year>
<volume>30</volume>
<issue>3</issue>
<fpage>137</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="pmid">24461309</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aparecida da Silva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cordeiro</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Louza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vallada</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Lack of association between a 3′UTR VNTR polymorphism of dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of adult patients</article-title>
<source/>J Atten Disord
          <year>2011</year>
<volume>15</volume>
<issue>4</issue>
<fpage>305</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="pmid">20332413</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Brookes</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ebstein</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Banaschewski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sonuga-Barke</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Eisenberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Manor</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Miranda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oades</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Roeyers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rothenberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sergeant</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Steinhausen</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
</person-group>
<article-title>Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD</article-title>
<source/>Am J Psychiatry
          <year>2007</year>
<volume>164</volume>
<issue>4</issue>
<fpage>674</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="pmid">17403983</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakker</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>van der Meulen</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Oteman</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schelleman</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Sinke</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families</article-title>
<source/>Am J Med Genet B
          <year>2005</year>
<volume>132B</volume>
<issue>1</issue>
<fpage>50</fpage>
<lpage>52</lpage>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banoei</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Majidizadeh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shirazi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Moghimi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ghadiri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Najmabadi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohadi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>No association between the DAT1 10-repeat allele and ADHD in the Iranian population</article-title>
<source/>Am J Med Genet B
          <year>2008</year>
<volume>147B</volume>
<issue>1</issue>
<fpage>110</fpage>
<lpage>111</lpage>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bax</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tsuruta</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Moons</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>Development and validation of MIX: comprehensive free software for meta-analysis of causal research data</article-title>
<source/>BMC Med Res Methodol
          <year>2006</year>
<volume>6</volume>
<fpage>50</fpage>
<pub-id pub-id-type="pmid">17038197</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Begg</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Mazumdar</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Operating characteristics of a rank correlation test for publication bias</article-title>
<source/>Biometrics
          <year>1994</year>
<volume>50</volume>
<issue>4</issue>
<fpage>1088</fpage>
<lpage>1101</lpage>
<pub-id pub-id-type="pmid">7786990</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bidwell</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Willcutt</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>McQueen</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>DeFries</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>BF</given-names>
</name>
</person-group>
<article-title>A family based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorder</article-title>
<source/>Behav Genet
          <year>2011</year>
<volume>41</volume>
<issue>1</issue>
<fpage>165</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="pmid">21207241</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bobb</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Addington</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Sidransky</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gornick</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Greenstein</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Clasen</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Inoff-Germain</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wavrant-De Vrieze</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Arcos-Burgos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Straub</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Castellanos</surname>
<given-names>FX</given-names>
</name>
<name>
<surname>Rapoport</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Support for association between ADHD and two candidate genes: NET1 and DRD1</article-title>
<source/>Am J Med Genet Part B Neuropsychiatr Genet
          <year>2005</year>
<volume>134b</volume>
<issue>1</issue>
<fpage>67</fpage>
<lpage>72</lpage>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonvicini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Scassellati</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<issue>7</issue>
<fpage>872</fpage>
<lpage>884</lpage>
<pub-id pub-id-type="pmid">27217152</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borenstein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hedges</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Higgins</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>HR</given-names>
</name>
</person-group>
<article-title>A basic introduction to fixed-effect and random-effects models for meta-analysis</article-title>
<source/>Res Synth Methods
          <year>2010</year>
<volume>1</volume>
<issue>2</issue>
<fpage>97</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="pmid">26061376</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brookes</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ebstein</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Andreou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Altink</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Boer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Buschgens</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Christiansen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fleischman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fliers</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Howe-Forbes</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Goldfarb</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heise</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gabriels</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Korn-Lubetzki</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marco</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Medad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Minderaa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mulas</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Mulligan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rabin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rommelse</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sethna</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sorohan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Uebel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Psychogiou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Weeks</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Banaschewski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sonuga-Barke</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Eisenberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kuntsi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Manor</surname>
<given-names>I</given-names>
</name>
<name>
<surname>McGuffin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Miranda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oades</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Plomin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Roeyers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rothenberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sergeant</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Steinhausen</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes</article-title>
<source/>Mol Psychiatry
          <year>2006</year>
<volume>11</volume>
<issue>10</issue>
<fpage>934</fpage>
<lpage>953</lpage>
<pub-id pub-id-type="pmid">16894395</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brookes</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Sugden</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>D’Souza</surname>
<given-names>UM</given-names>
</name>
</person-group>
<article-title>Relationship between VNTR Polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue</article-title>
<source/>Am J Med Genet B
          <year>2007</year>
<volume>144B</volume>
<issue>8</issue>
<fpage>1070</fpage>
<lpage>1078</lpage>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brüggemann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sobanski</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Alm</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schmalzried</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Philipsen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Breen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Georgi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Skowronek</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Treutlein</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rietschel</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>No association between a common haplotype of the 6 and 10-repeat alleles in intron 8 and the 3′UTR of the DAT1 gene and adult attention deficit hyperactivity disorder</article-title>
<source/>Psychiatr Genet
          <year>2007</year>
<volume>17</volume>
<issue>2</issue>
<fpage>121</fpage>
<pub-id pub-id-type="pmid">17413453</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrasco</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Rothhammer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Moraga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Henriquez</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Aboitiz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rothhammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Presence of DRD4/7R and DAT1/10R allele in Chilean family members with attention deficit hyperactivity disorder</article-title>
<source/>Rev Medica Chile
          <year>2004</year>
<volume>132</volume>
<issue>9</issue>
<fpage>1047</fpage>
<lpage>1052</lpage>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheuk</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>No association between VNTR polymorphisms of dopamine transporter gene and attention deficit hyperactivity disorder in Chinese children</article-title>
<source/>Am J Med Genet Part B Neuropsychiatr Genet
          <year>2006</year>
<volume>141b</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>125</lpage>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Krasowski</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Olkon</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Kieffer</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>Association of attention-deficit disorder and the dopamine transporter gene</article-title>
<source/>Am J Hum Genet
          <year>1995</year>
<volume>56</volume>
<issue>4</issue>
<fpage>993</fpage>
<lpage>998</lpage>
<pub-id pub-id-type="pmid">7717410</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tahir</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gould</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Huckett</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Batten</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fernando</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ozbay</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yazgan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Simonoff</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples</article-title>
<source/>Mol Psychiatry
          <year>2001</year>
<volume>6</volume>
<issue>4</issue>
<fpage>425</fpage>
<lpage>428</lpage>
<pub-id pub-id-type="pmid">11443527</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Das Bhowmik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bhaduri</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Role of gene–gene/gene–environment interaction in the etiology of eastern Indian ADHD probands</article-title>
<source/>Prog Neuro-Psychopharmacol Biol Psychiatry
          <year>2011</year>
<volume>35</volume>
<issue>2</issue>
<fpage>577</fpage>
<lpage>587</lpage>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Azeredo</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Rovaris</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Mota</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Polina</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Marques</surname>
<given-names>FZ</given-names>
</name>
<name>
<surname>Contini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Vitola</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Belmonte-de-Abreu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Grevet</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Bau</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults</article-title>
<source/>Eur Arch Psychiatry Clin Neurosci
          <year>2014</year>
<volume>264</volume>
<issue>5</issue>
<fpage>401</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="pmid">24487615</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demontis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mattheisen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Als</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Agerbo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Baldursson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Belliveau</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bybjerg-Grauholm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Baekvad-Hansen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cerrato</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chambert</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Churchhouse</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dumont</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gandal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Grasby</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Grove</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gudmundsson</surname>
<given-names>OO</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Hauberg</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Hollegaard</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Howrigan</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Maller</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pallesen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Poterba</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Poulsen</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Ripke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Satterstrom</surname>
<given-names>FK</given-names>
</name>
<name>
<surname>Stefansson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Turley</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Consortium</surname>
<given-names>AWGotPG</given-names>
</name>
<name>
<surname>Early</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Genetic Epidemiology</surname>
<given-names>C</given-names>
</name>
<name>
<surname>andMe Research</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Andreassen</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Boomsma</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Cormand</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dalsgaard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gelernter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Haavik</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kranzler</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Kuntsi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Langley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Middeldorp</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Reif</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Roussos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Schachar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sonuga-Barke</surname>
<given-names>EJS</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Thapar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Waldman</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Medland</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Stefansson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nordentoft</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hougaard</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Werge</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mors</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Mortensen</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Borglum</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>BM</given-names>
</name>
</person-group>
<article-title>Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder</article-title>
<source/>Nat Genet
          <year>2019</year>
<volume>51</volume>
<issue>1</issue>
<fpage>63</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">30478444</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dilling</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Freyberger</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Stieglitz</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>ICD-10 field trial of the diagnostic criteria for research in German-speaking countries</article-title>
<source/>Introd Psychopathol
          <year>1996</year>
<volume>29</volume>
<issue>5</issue>
<fpage>258</fpage>
<lpage>259</lpage>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doucette-Stamm</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Blakely</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mockus</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>Population genetic study of the human dopamine transporter gene (DAT1)</article-title>
<source/>Genet Epidemiol
          <year>1995</year>
<volume>12</volume>
<issue>3</issue>
<fpage>303</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="pmid">7557351</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dresler</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ehlis</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Heinzel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Reif</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Baehne</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Heine</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boreatti-Hummer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Fallgatter</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD</article-title>
<source/>Neuropsychopharmacology
          <year>2010</year>
<volume>35</volume>
<issue>11</issue>
<fpage>2193</fpage>
<lpage>2202</lpage>
<pub-id pub-id-type="pmid">20631685</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>The association between the SLC6A3 VNTR 9-repeat allele and alcoholism-a meta-analysis</article-title>
<source/>Alcohol Clin Exp Res
          <year>2011</year>
<volume>35</volume>
<issue>9</issue>
<fpage>1625</fpage>
<lpage>1634</lpage>
<pub-id pub-id-type="pmid">21554332</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duval</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tweedie</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis</article-title>
<source/>Biometrics
          <year>2000</year>
<volume>56</volume>
<issue>2</issue>
<fpage>455</fpage>
<lpage>463</lpage>
<pub-id pub-id-type="pmid">10877304</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Davey Smith</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Minder</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>
<source/>BMJ
          <year>1997</year>
<volume>315</volume>
<issue>7109</issue>
<fpage>629</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="pmid">9310563</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Tarras</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Alsulaimani</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Awad</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Mitwaly</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Said</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Sabry</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Association study between the dopamine-related candidate gene polymorphisms and ADHD among Saudi Arabia population via PCR technique</article-title>
<source/>Mol Biol Rep
          <year>2012</year>
<volume>39</volume>
<issue>12</issue>
<fpage>11081</fpage>
<lpage>11086</lpage>
<pub-id pub-id-type="pmid">23076524</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis</article-title>
<source/>Eur Child Adolesc Psychiatry
          <year>2010</year>
<volume>19</volume>
<issue>4</issue>
<fpage>353</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="pmid">19763664</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Genetics of attention deficit hyperactivity disorder</article-title>
<source/>Mol Psychiatry
          <year>2018</year>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Madras</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Zhang-James</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<issue>8</issue>
<fpage>880</fpage>
<lpage>889</lpage>
<pub-id pub-id-type="pmid">24061496</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feher</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Juhasz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pakaski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kalman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Janka</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Association between the 9 repeat allele of the dopamine transporter 40 bp variable tandem repeat polymorphism and Alzheimer’s disease</article-title>
<source/>Psychiatry Res
          <year>2014</year>
<volume>220</volume>
<issue>1–2</issue>
<fpage>730</fpage>
<lpage>731</lpage>
<pub-id pub-id-type="pmid">25130782</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wigg</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Makkar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ickowicz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pathare</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tannock</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Malone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Schachar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Barr</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Sequence variation in the 3′-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD)</article-title>
<source/>Am J Med Genet B
          <year>2005</year>
<volume>139B</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonseca</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Mateus</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Galvez</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Forero</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Talero-Gutierrez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Velez-van-Meerbeke</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Lack of association of polymorphisms in six candidate genes in colombian adhd patients</article-title>
<source/>Ann Neurosci
          <year>2015</year>
<volume>22</volume>
<issue>4</issue>
<fpage>217</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">26526368</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hoogman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arias Vasquez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heister</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Savelkoul</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Naber</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kiemeney</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Kooij</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>Association of the dopamine transporter (SLC6A3/DAT1) gene 9–6 haplotype with adult ADHD</article-title>
<source/>Am J Med Genet Part B Neuropsychiatr Genet
          <year>2008</year>
<volume>147b</volume>
<issue>8</issue>
<fpage>1576</fpage>
<lpage>1579</lpage>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Vasquez</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoogman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Romanos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Boreatti-Hummer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heine</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Casas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ribases</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sanchez-Mora</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gomez-Barros</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fernandez-Castillo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bayes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Halmoy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Halleland</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Landaas</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Fasmer</surname>
<given-names>OB</given-names>
</name>
<name>
<surname>Knappskog</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Heister</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kiemeney</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Kooij</surname>
<given-names>JJS</given-names>
</name>
<name>
<surname>Boonstra</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Haavik</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cormand</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ramos-Quiroga</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Reif</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD</article-title>
<source/>Neuropsychopharmacology
          <year>2010</year>
<volume>35</volume>
<issue>3</issue>
<fpage>656</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="pmid">19890261</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saar</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sauer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dempfle</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Walitza</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Romanos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Freitag</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Seitz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Palmason</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Scherag</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Windemuth-Kieselbach</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schimmelmann</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Wewetzer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Warnke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Reinhardt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Herpertz-Dahlmann</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Linder</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hinney</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Remschmidt</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schafer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Konrad</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hubner</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hebebrand</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Association and linkage of allelic variants of the dopamine transporter gene in ADHD</article-title>
<source/>Mol Psychiatry
          <year>2007</year>
<volume>12</volume>
<issue>10</issue>
<fpage>923</fpage>
<lpage>933</lpage>
<pub-id pub-id-type="pmid">17579611</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Koike</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sasagawa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ishiura</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression</article-title>
<source/>Pharmacogenomics J
          <year>2001</year>
<volume>1</volume>
<issue>2</issue>
<fpage>152</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="pmid">11911442</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galili-Weisstub</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Frisch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gross-Tsur</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Michaelovsky</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kosov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goltser</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Serretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cusin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Darvasi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Inbar</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Weizman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Segman</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Dopamine transporter haplotype and attention-deficit hyperactivity disorder</article-title>
<source/>Mol Psychiatry
          <year>2005</year>
<volume>10</volume>
<issue>7</issue>
<fpage>617</fpage>
<lpage>618</lpage>
<pub-id pub-id-type="pmid">15940306</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gamma</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Glatt</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Tsuang</surname>
<given-names>MT</given-names>
</name>
</person-group>
<article-title>Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene</article-title>
<source/>Schizophr Res
          <year>2005</year>
<volume>73</volume>
<issue>1</issue>
<fpage>55</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="pmid">15567077</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geissler</surname>
<given-names>JM</given-names>
</name>
<collab>International Parkinson Disease Genomics Consortium M</collab>
<name>
<surname>Romanos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gerlach</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease in nine ADHD candidate SNPs</article-title>
<source/>Attent Deficit Hyperact Disord
          <year>2017</year>
<volume>9</volume>
<issue>2</issue>
<fpage>121</fpage>
<lpage>127</lpage>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genro</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Polanczyk</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Zeni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Roman</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Hutz</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>A common haplotype at the dopamine transporter gene 5′ region is associated with attention-deficit/hyperactivity disorder</article-title>
<source/>Am J Med Genet B
          <year>2008</year>
<volume>147B</volume>
<issue>8</issue>
<fpage>1568</fpage>
<lpage>1575</lpage>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gizer</surname>
<given-names>IR</given-names>
</name>
<name>
<surname>Ficks</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Waldman</surname>
<given-names>ID</given-names>
</name>
</person-group>
<article-title>Candidate gene studies of ADHD: a meta-analytic review</article-title>
<source/>Hum Genet
          <year>2009</year>
<volume>126</volume>
<issue>1</issue>
<fpage>51</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">19506906</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomez-Sanchez</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>Riveiro-Alvarez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Soto-Insuga</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rodrigo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tirado-Requero</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mahillo-Fernandez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Abad-Santos</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Carballo</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Dal-Re</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ayuso</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Attention deficit hyperactivity disorder: genetic association study in a cohort of Spanish children</article-title>
<source/>Behav Brain Funct
          <year>2016</year>
<volume>12</volume>
<fpage>10</fpage>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenwood</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Kelsoe</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene</article-title>
<source/>Genomics
          <year>2003</year>
<volume>82</volume>
<issue>5</issue>
<fpage>511</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="pmid">14559208</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Grob</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hagmann-von Arx</surname>
<given-names>P</given-names>
</name>
</person-group>
<source/>Intelligence and development scales (IDS). Intelligenz- und Entwicklungsskalen für Kinder von 5-10 Jahren
          <year>2009</year>
<publisher-loc>Bern</publisher-loc>
<publisher-name>Verlag Hans Huber</publisher-name>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>HH</given-names>
</name>
</person-group>
<article-title>Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs</article-title>
<source/>BMC Pharmacol
          <year>2006</year>
<volume>6</volume>
<fpage>6</fpage>
<pub-id pub-id-type="pmid">16515684</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Salzmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bolzan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zimmermann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Baud</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Giannakopoulos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Perroud</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>DAT1 and DRD4 genes involved in key dimensions of adult ADHD</article-title>
<source/>Neurol Sci
          <year>2015</year>
<volume>36</volume>
<issue>6</issue>
<fpage>861</fpage>
<lpage>869</lpage>
<pub-id pub-id-type="pmid">25555995</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hawi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Segurado</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Conroy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sheehan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kirley</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shields</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder</article-title>
<source/>Am J Hum Genet
          <year>2005</year>
<volume>77</volume>
<issue>6</issue>
<fpage>958</fpage>
<lpage>965</lpage>
<pub-id pub-id-type="pmid">16380908</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hawi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Brookes</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Banaschewski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ebstein</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Miranda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oades</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Roeyers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rothenberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sergeant</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sonuga-Barke</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Steinhausen</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>ADHD and DAT1: further evidence of paternal over-transmission of risk alleles and haplotype</article-title>
<source/>Am J Med Genet Part B Neuropsychiatr Genet
          <year>2010</year>
<volume>153b</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>102</lpage>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hebebrand</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dempfle</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saar</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Thiele</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Herpertz-Dahlmann</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Linder</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kiefl</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Remschmidt</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hemminger</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Warnke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Knolker</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Heiser</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Friedel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hinney</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schafer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nurnberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Konrad</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs</article-title>
<source/>Mol Psychiatry
          <year>2006</year>
<volume>11</volume>
<issue>2</issue>
<fpage>196</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="pmid">16222334</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hawi</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Functional analysis of intron 8 and 3′ UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants</article-title>
<source/>Pharmacogenomics J
          <year>2010</year>
<volume>10</volume>
<issue>5</issue>
<fpage>442</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="pmid">20029387</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>IW</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children</article-title>
<source/>Genes Genom
          <year>2018</year>
<volume>40</volume>
<issue>12</issue>
<fpage>1309</fpage>
<lpage>1317</lpage>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoogman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Onnink</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cools</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Aarts</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Arias Vasquez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The dopamine transporter haplotype and reward-related striatal responses in adult ADHD</article-title>
<source/>Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol
          <year>2013</year>
<volume>23</volume>
<issue>6</issue>
<fpage>469</fpage>
<lpage>478</lpage>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue-Murayama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mishima</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mitani</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Terao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hayasaka</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Murayama</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Variation of variable number of tandem repeat sequences in the 3′-untranslated region of primate dopamine transporter genes that affects reporter gene expression</article-title>
<source/>Neurosci Lett
          <year>2002</year>
<volume>334</volume>
<issue>3</issue>
<fpage>206</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="pmid">12453630</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iversen</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Iversen</surname>
<given-names>LL</given-names>
</name>
</person-group>
<article-title>Dopamine: 50 years in perspective</article-title>
<source/>Trends Neurosci
          <year>2007</year>
<volume>30</volume>
<issue>5</issue>
<fpage>188</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="pmid">17368565</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>miR-137 and miR-491 negatively regulate dopamine transporter expression and function in neural cells</article-title>
<source/>Neurosci Bull
          <year>2016</year>
<volume>32</volume>
<issue>6</issue>
<fpage>512</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="pmid">27628529</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The relationship between attention-deficit hyperactivity disorder and dopamine transporter 1 gene</article-title>
<source/>Chin J Nerv Ment Dis
          <year>1999</year>
<volume>25</volume>
<fpage>355</fpage>
<lpage>357</lpage>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johansson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Halleland</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Halmoy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Landaas</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Dramsdahl</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fasmer</surname>
<given-names>OB</given-names>
</name>
<name>
<surname>Bergsholm</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lundervold</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hugdahl</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Knappskog</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Haavik</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs</article-title>
<source/>Am J Med Genet B
          <year>2008</year>
<volume>147B</volume>
<issue>8</issue>
<fpage>1470</fpage>
<lpage>1475</lpage>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanno</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ishiura</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Differential effects of the HESR/HEY transcription factor family on dopamine transporter reporter gene expression via variable number of tandem repeats</article-title>
<source/>J Neurosci Res
          <year>2011</year>
<volume>89</volume>
<issue>4</issue>
<fpage>562</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="pmid">21290414</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Kaufman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>N</given-names>
</name>
</person-group>
<source/>K-ABC: Kaufman-assessment battery for children
          <year>1983</year>
<publisher-loc>Circle Pines</publisher-loc>
<publisher-name>American Guidance Service</publisher-name>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kereszturi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tarnok</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bognar</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lakatos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Farkas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gadoros</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sasvari-Szekely</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nemoda</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Catechol-<italic>O</italic>-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children</article-title>
<source/>Am J Med Genet B
          <year>2008</year>
<volume>147B</volume>
<issue>8</issue>
<fpage>1431</fpage>
<lpage>1435</lpage>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Cheon</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Badner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
</person-group>
<article-title>Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD</article-title>
<source/>Neurosci Lett
          <year>2005</year>
<volume>390</volume>
<issue>3</issue>
<fpage>176</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="pmid">16165273</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case–control association study in a Korean sample</article-title>
<source/>J Psychiatry Res
          <year>2006</year>
<volume>40</volume>
<issue>8</issue>
<fpage>730</fpage>
<lpage>737</lpage>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kopeckova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Paclt</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Petrasek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pacltova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Malikova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zagatova</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case–control study of 100 subjects 6–10 age</article-title>
<source/>Neuroendocrinol Lett
          <year>2008</year>
<volume>29</volume>
<issue>2</issue>
<fpage>246</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="pmid">18404133</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kustanovich</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McGough</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>McCracken</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Smalley</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>SF</given-names>
</name>
</person-group>
<article-title>Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5</article-title>
<source/>Mol Psychiatry
          <year>2004</year>
<volume>9</volume>
<issue>7</issue>
<fpage>711</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="pmid">14699430</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Turic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Peirce</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Van den Bree</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>O’Donovan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Thapar</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>No support for association between the dopamine transporter (DAT1) gene and ADHD</article-title>
<source/>Am J Med Genet B
          <year>2005</year>
<volume>139B</volume>
<issue>1</issue>
<fpage>7</fpage>
<lpage>10</lpage>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD)</article-title>
<source/>Hum Mol Genet
          <year>2006</year>
<volume>15</volume>
<issue>14</issue>
<fpage>2276</fpage>
<lpage>2284</lpage>
<pub-id pub-id-type="pmid">16774975</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The association between genetic variants in the dopaminergic system and posttraumatic stress disorder: a meta-analysis</article-title>
<source/>Medicine (Baltimore)
          <year>2016</year>
<volume>95</volume>
<issue>11</issue>
<fpage>e3074</fpage>
<pub-id pub-id-type="pmid">26986136</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liberati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Tetzlaff</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mulrow</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gotzsche</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Ioannidis</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Devereaux</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Kleijnen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moher</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration</article-title>
<source/>PLoS Med
          <year>2009</year>
<volume>6</volume>
<issue>7</issue>
<fpage>e1000100</fpage>
<pub-id pub-id-type="pmid">19621070</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Paik</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): a family-based approach</article-title>
<source/>Am J Med Genet B
          <year>2006</year>
<volume>141B</volume>
<issue>3</issue>
<fpage>309</fpage>
<lpage>311</lpage>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Quan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Association between genetic variants in SLC25A12 and risk of autism spectrum disorders: an integrated meta-analysis</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2015</year>
<volume>168B</volume>
<issue>4</issue>
<fpage>236</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="pmid">25921325</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Leon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Janssens</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Gonzalez-Zuloeta Ladd</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Del-Favero</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Oostra</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>van Duijn</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Meta-analyses of genetic studies on major depressive disorder</article-title>
<source/>Mol Psychiatry
          <year>2008</year>
<volume>13</volume>
<issue>8</issue>
<fpage>772</fpage>
<lpage>785</lpage>
<pub-id pub-id-type="pmid">17938638</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lunetta</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Laird</surname>
<given-names>NM</given-names>
</name>
</person-group>
<article-title>Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions</article-title>
<source/>Am J Hum Genet
          <year>2000</year>
<volume>66</volume>
<issue>2</issue>
<fpage>605</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="pmid">10677320</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maher</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Marazita</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Ferrell</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Vanyukov</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis</article-title>
<source/>Psychiatr Genet
          <year>2002</year>
<volume>12</volume>
<issue>4</issue>
<fpage>207</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="pmid">12454525</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markowitz</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Patrick</surname>
<given-names>KS</given-names>
</name>
</person-group>
<article-title>Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?</article-title>
<source/>J Clin Psychopharmacol
          <year>2008</year>
<volume>28</volume>
<issue>3 Suppl 2</issue>
<fpage>S54</fpage>
<lpage>S61</lpage>
<pub-id pub-id-type="pmid">18480678</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Levy</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Diaz-Galvis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Briones-Velasco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gomez-Sanchez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>De la Pena-Olvera</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sosa-Mora</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Palacios-Cruz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ricardo-Garcell</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Reyes-Zamorano</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cruz-Fuentes</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients</article-title>
<source/>Neurosci Lett
          <year>2009</year>
<volume>451</volume>
<issue>3</issue>
<fpage>257</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="pmid">19146920</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Levy</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Benjet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Briones-Velasco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perez-Molina</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cruz-Fuentes</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>Genetic variability of DRD4 and DAT1 in the urban population of Mexico City</article-title>
<source/>Salud Ment
          <year>2013</year>
<volume>36</volume>
<issue>3</issue>
<fpage>189</fpage>
<lpage>192</lpage>
</element-citation>
</ref>
<ref id="CR79">
<mixed-citation publication-type="other">Mazei-Robinson MS, Blakely RD (2006) ADHD and the dopamine transporter: are there reasons to pay attention? Handb Exp Pharmacol (175):373–415</mixed-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McHugh</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>The structure and function of the dopamine transporter and its role in CNS diseases</article-title>
<source/>Vitam Horm
          <year>2015</year>
<volume>98</volume>
<fpage>339</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="pmid">25817874</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Melchers</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Preuss</surname>
<given-names>U</given-names>
</name>
</person-group>
<source/>K-ABC: Kaufman-asessment battery for children. Deutsche Bearbeitung
          <year>1994</year>
<publisher-loc>Amsterdam</publisher-loc>
<publisher-name>Swets&amp;Zeitglinger</publisher-name>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mick</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wozniak</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wilens</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Smoller</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
</person-group>
<article-title>Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3)</article-title>
<source/>Am J Med Genet B
          <year>2008</year>
<volume>147B</volume>
<issue>7</issue>
<fpage>1182</fpage>
<lpage>1185</lpage>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mill</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Browes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>D’Souza</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR</article-title>
<source/>Am J Med Genet
          <year>2002</year>
<volume>114</volume>
<issue>8</issue>
<fpage>975</fpage>
<lpage>979</lpage>
<pub-id pub-id-type="pmid">12457396</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mill</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>I</given-names>
</name>
<name>
<surname>D’Souza</surname>
<given-names>UM</given-names>
</name>
</person-group>
<article-title>Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1)</article-title>
<source/>BMC Genet
          <year>2005</year>
<volume>6</volume>
<fpage>3</fpage>
<pub-id pub-id-type="pmid">15683546</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Madras</surname>
<given-names>BK</given-names>
</name>
</person-group>
<article-title>Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression</article-title>
<source/>Mol Psychiatry
          <year>2002</year>
<volume>7</volume>
<issue>1</issue>
<fpage>44</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="pmid">11803445</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Caplan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Norona</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SS</given-names>
</name>
</person-group>
<article-title>COMT and DAT1 polymorphisms moderate the indirect effect of parenting behavior on youth ADHD symptoms through neurocognitive functioning</article-title>
<source/>Child Neuropsychol
          <year>2018</year>
<volume>24</volume>
<issue>6</issue>
<fpage>823</fpage>
<lpage>843</lpage>
<pub-id pub-id-type="pmid">28675949</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niederhofer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Menzel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gobel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hackenberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pycha</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Menzel</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>A preliminary report of the dopamine receptor D(4) and the dopamine transporter 1 gene polymorphism and its association with attention deficit hyperactivity disorder</article-title>
<source/>Neuropsychiatr Dis Treat
          <year>2008</year>
<volume>4</volume>
<issue>4</issue>
<fpage>701</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="pmid">19043512</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onnink</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>van Hulzen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zwiers</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Mostert</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Schene</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Heslenfeld</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Oosterlaan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hoekstra</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Hartman</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Vasquez</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hoogman</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Enlarged striatal volume in adults with ADHD carrying the 9–6 haplotype of the dopamine transporter gene DAT1</article-title>
<source/>J Neural Transm (Vienna, Austria: 1996)
          <year>2016</year>
<volume>123</volume>
<issue>8</issue>
<fpage>905</fpage>
<lpage>915</lpage>
</element-citation>
</ref>
<ref id="CR89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortega-Rojas</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arboleda-Bustos</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Benitez</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Beltran</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Izquierdo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Arboleda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vasquez</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Study of genetic variants in the BDNF, COMT, DAT1 and SERT genes in Colombian children with attention deficit disorder</article-title>
<source/>Revista colombiana de psiquiatria
          <year>2017</year>
<volume>46</volume>
<issue>4</issue>
<fpage>222</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="pmid">29122229</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinsonneault</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Burdick</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Kataki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bertolino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Sadee</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder</article-title>
<source/>Neuropsychopharmacology
          <year>2011</year>
<volume>36</volume>
<issue>8</issue>
<fpage>1644</fpage>
<lpage>1655</lpage>
<pub-id pub-id-type="pmid">21525861</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polanczyk</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Willcutt</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Salum</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Kieling</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis</article-title>
<source/>Int J Epidemiol
          <year>2014</year>
<volume>43</volume>
<issue>2</issue>
<fpage>434</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="pmid">24464188</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Politi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ciccacci</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Novelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Borgiani</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Genetics and treatment response in Parkinson’s disease: an update on pharmacogenetic studies</article-title>
<source/>Neuromolecular Med
          <year>2018</year>
<volume>20</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="pmid">29305687</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Todd-Brown</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Bender</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Maller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>de Bakker</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>81</volume>
<issue>3</issue>
<fpage>559</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="pmid">17701901</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qian</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Glatt</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
</person-group>
<article-title>Evaluation of potential gene–gene interactions for attention deficit hyperactivity disorder in the Han Chinese population</article-title>
<source/>Am J Med Genet Part B Neuropsychiatr Genet
          <year>2007</year>
<volume>144b</volume>
<issue>2</issue>
<fpage>200</fpage>
<lpage>206</lpage>
</element-citation>
</ref>
<ref id="CR95">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sambataro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Podell</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Murty</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kolachana</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Weinberger</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Mattay</surname>
<given-names>VS</given-names>
</name>
</person-group>
<article-title>A variable number of tandem repeats in the 3′-untranslated region of the dopamine transporter modulates striatal function during working memory updating across the adult age span</article-title>
<source/>Eur J Neurosci
          <year>2015</year>
<volume>42</volume>
<issue>3</issue>
<fpage>1912</fpage>
<lpage>1918</lpage>
<pub-id pub-id-type="pmid">25997640</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sery</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Paclt</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Drtilkova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Theiner</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kopeckova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zvolsky</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Balcar</surname>
<given-names>VJ</given-names>
</name>
</person-group>
<article-title>A 40-bp VNTR polymorphism in the 3′-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism</article-title>
<source/>Behav Brain Funct
          <year>2015</year>
<volume>11</volume>
<fpage>8</fpage>
<pub-id pub-id-type="pmid">25888969</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Gau</surname>
<given-names>SS</given-names>
</name>
</person-group>
<article-title>Association between the DAT1 gene and spatial working memory in attention deficit hyperactivity disorder</article-title>
<source/>Int J Neuropsychopharmacol
          <year>2014</year>
<volume>17</volume>
<issue>1</issue>
<fpage>9</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">24008096</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simsek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Al-Sharbati</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Al-Adawi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ganguly</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Lawatia</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Association of the risk allele of dopamine transporter gene (DAT1*10) in Omani male children with attention-deficit hyperactivity disorder</article-title>
<source/>Clin Biochem
          <year>2005</year>
<volume>38</volume>
<issue>8</issue>
<fpage>739</fpage>
<lpage>742</lpage>
<pub-id pub-id-type="pmid">15993876</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yiannoutsos</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Barkley</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Navia</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study</article-title>
<source/>Am J Med Genet B
          <year>2003</year>
<volume>119B</volume>
<issue>1</issue>
<fpage>77</fpage>
<lpage>85</lpage>
</element-citation>
</ref>
<ref id="CR100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soleimani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Salehi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Soltanipour</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hasandokht</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jalali</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>SLC6A3 polymorphism and response to methylphenidate in children with ADHD: a systematic review and meta-analysis</article-title>
<source/>Am J Med Genet B
          <year>2018</year>
<volume>177</volume>
<issue>3</issue>
<fpage>287</fpage>
<lpage>300</lpage>
</element-citation>
</ref>
<ref id="CR101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanley</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chavda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Prabhu</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Ashavaid</surname>
<given-names>TF</given-names>
</name>
</person-group>
<article-title>DRD4 and DAT1 VNTR genotyping in children with attention deficit hyperactivity disorder</article-title>
<source/>Indian J Clin Biochem
          <year>2017</year>
<volume>32</volume>
<issue>2</issue>
<fpage>239</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="pmid">28428702</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Flodman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Spence</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Moyzis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schuck</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Murias</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moriarity</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barr</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Posner</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Dopamine genes and ADHD</article-title>
<source/>Neurosci Biobehav Rev
          <year>2000</year>
<volume>24</volume>
<issue>1</issue>
<fpage>21</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="pmid">10654656</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarnok</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ronai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gervai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kereszturi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gadoros</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sasvari-Szekely</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nemoda</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3′ UTR polymorphism of the dopamine transporter gene</article-title>
<source/>Am J Med Genet Part B Neuropsychiatr Genet
          <year>2007</year>
<volume>144B</volume>
<issue>7</issue>
<fpage>900</fpage>
<lpage>905</lpage>
</element-citation>
</ref>
<ref id="CR104">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies</article-title>
<source/>Mol Psychiatry
          <year>2013</year>
<volume>18</volume>
<issue>7</issue>
<fpage>799</fpage>
<lpage>805</lpage>
<pub-id pub-id-type="pmid">22665263</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Tellegen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Winkel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Laros</surname>
<given-names>J</given-names>
</name>
</person-group>
<source/>Snijders Oomen non-verbal intelligence test revised (SON-R)
          <year>2003</year>
<publisher-loc>Göttingen</publisher-loc>
<publisher-name>Hofgrefe-Verlag</publisher-name>
</element-citation>
</ref>
<ref id="CR106">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Tewes</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Rossmann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>U</surname>
<given-names>S</given-names>
</name>
</person-group>
<source/>Der Hamburg-Wechsler-Intelligenztest für Kinder (HAWIK-III)-3. Auflage
          <year>1999</year>
<edition>3</edition>
<publisher-loc>Bern</publisher-loc>
<publisher-name>Huber-Verlag</publisher-name>
</element-citation>
</ref>
<ref id="CR107">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Doust</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Beller</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Glasziou</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis</article-title>
<source/>Pediatrics
          <year>2015</year>
<volume>135</volume>
<issue>4</issue>
<fpage>e994</fpage>
<lpage>e1001</lpage>
<pub-id pub-id-type="pmid">25733754</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Todd</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Jong</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Lobos</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Reich</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Heath</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Neuman</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins</article-title>
<source/>Am J Med Genet
          <year>2001</year>
<volume>105</volume>
<issue>8</issue>
<fpage>745</fpage>
<lpage>748</lpage>
<pub-id pub-id-type="pmid">11803523</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ujike</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Harano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Inada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Komiyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sekine</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sora</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Iyo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Katsu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nakata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis</article-title>
<source/>Pharmacogenomics J
          <year>2003</year>
<volume>3</volume>
<issue>4</issue>
<fpage>242</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">12931138</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>VanNess</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kilts</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density</article-title>
<source/>BMC Genet
          <year>2005</year>
<volume>6</volume>
<fpage>55</fpage>
<pub-id pub-id-type="pmid">16309561</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waldman</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Rowe</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Abramowitz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kozel</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Mohr</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Card</surname>
<given-names>JHC</given-names>
</name>
<name>
<surname>Stever</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity</article-title>
<source/>Am J Hum Genet
          <year>1998</year>
<volume>63</volume>
<issue>6</issue>
<fpage>1767</fpage>
<lpage>1776</lpage>
<pub-id pub-id-type="pmid">9837830</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shirakawa</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Lack of association between the dopamine transporter gene 3′ VNTR polymorphism and attention deficit hyperactivity disorder in Chinese Han children: case–control and family-based studies</article-title>
<source/>Kobe J Med Sci
          <year>2008</year>
<volume>53</volume>
<issue>6</issue>
<fpage>327</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="pmid">18762727</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Wechsler</surname>
<given-names>D</given-names>
</name>
</person-group>
<source/>Examiner’s manual: Wechsler Intelligence Scale for children
          <year>1991</year>
<edition>3</edition>
<publisher-loc>San Antonio</publisher-loc>
<publisher-name>The Psychological Corporation</publisher-name>
</element-citation>
</ref>
<ref id="CR114">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>R</given-names>
</name>
</person-group>
<source/>Grundintelligenztest Skala 2-Revision (CFT 20-R) mit Wortschatztest und Zahlenfolgentest-Revision (Ws/ZF-R)
          <year>2006</year>
<publisher-loc>Göttingen</publisher-loc>
<publisher-name>Hofgrefe-Verlag</publisher-name>
</element-citation>
</ref>
<ref id="CR115">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiers</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Lohoff</surname>
<given-names>FW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Muench</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zehra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marenco</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lipska</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Auluck</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Volkow</surname>
<given-names>ND</given-names>
</name>
</person-group>
<article-title>Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: a preliminary study</article-title>
<source/>Eur J Neurosci
          <year>2018</year>
<volume>48</volume>
<issue>3</issue>
<fpage>1884</fpage>
<lpage>1895</lpage>
<pub-id pub-id-type="pmid">30033547</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiguna</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Winarsih</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Kaligis</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hapsari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Budiyanti</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sekartini</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rahayu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guerrero</surname>
<given-names>APS</given-names>
</name>
</person-group>
<article-title>Dopamine transporter gene polymorphism in children with ADHD: a pilot study in Indonesian samples</article-title>
<source/>Asian J Psychiatry
          <year>2017</year>
<volume>29</volume>
<fpage>35</fpage>
<lpage>38</lpage>
</element-citation>
</ref>
<ref id="CR117">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wohl</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Asch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cortese</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Orejarena</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mouren</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Gorwood</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Purper-Ouakil</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Lack of association of the dopamine transporter gene in a French ADHD sample</article-title>
<source/>Am J Med Genet Part B Neuropsychiatr Genet
          <year>2008</year>
<volume>147b</volume>
<issue>8</issue>
<fpage>1509</fpage>
<lpage>1510</lpage>
</element-citation>
</ref>
<ref id="CR118">
<mixed-citation publication-type="other">World Health Organization (2016) 10th international classification of diseases (ICD-10). WHO. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/classifications/icd/icdonlineversions/en/">http://www.who.int/classifications/icd/icdonlineversions/en/</ext-link>. Accessed 24 Feb 2017</mixed-citation>
</ref>
<ref id="CR119">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>RCK</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>RYL</given-names>
</name>
</person-group>
<article-title>A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention deficit hyperactivity disorder</article-title>
<source/>Am J Med Genet B
          <year>2007</year>
<volume>144B</volume>
<issue>4</issue>
<fpage>541</fpage>
<lpage>550</lpage>
</element-citation>
</ref>
<ref id="CR120">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Michelhaugh</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Bannon</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects</article-title>
<source/>Addict Biol
          <year>2014</year>
<volume>19</volume>
<issue>1</issue>
<fpage>122</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="pmid">22026501</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>